Clinical Trial Update: The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution. [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating low-dose interleukin-2 to map the immune cell landscape within human carotid atherosclerotic plaques at …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Carotid Artery Atherosclerosis
• Transient Ischemic Attack

Drugs mentioned

• Aldesleukin (Proleukin) (aldesleukin)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: TIA, Carotid Artery Plaque | NA | Status: ACTIVE_NOT_RECRUITING